Pediatric Hematology And Oncology

Journal Title：Pediatric Hematology And Oncology

PHO: Pediatric Hematology and Oncology covers all aspects of research and patient management within the area of blood disorders and malignant diseases of childhood. Our goal is to make PHO: Pediatric Hematology and Oncology the premier journal for the international community of clinicians and scientists who together aim to define optimal therapeutic strategies for children and young adults with cancer and blood disorders. The journal supports articles that address research in diverse clinical settings, exceptional case studies/series that add novel insights into pathogenesis and/or clinical care, and reviews highlighting discoveries and challenges emerging from consortia and conferences. Clinical studies as well as basic and translational research reports regarding cancer pathogenesis, genetics, molecular diagnostics, pharmacology, stem cells, molecular targeting, cellular and immune therapies and transplantation are of interest. Papers with a focus on supportive care, late effects and on related ethical, legal, psychological, social, cultural, or historical aspects of these fields are also appreciated. Reviews on important developments in the field are welcome. Articles from scientists and clinicians across the international community of Pediatric Hematology and Oncology are considered for publication. The journal is not dependent on or connected with any organization or society. All submissions undergo rigorous peer review prior to publication. Our Editorial Board includes experts in Pediatric Hematology and Oncology representing a wide range of academic and geographic diversity.

PHO：儿科血液学和肿瘤学涵盖了儿童血液疾病和恶性疾病领域内研究和患者管理的所有方面。我们的目标是使 PHO: Pediatric Hematology and Oncology 成为国际临床医生和科学家社区的首要期刊，他们共同致力于为患有癌症和血液疾病的儿童和年轻人制定最佳治疗策略。该杂志支持针对不同临床环境中的研究的文章、为发病机制和/或临床护理增加新见解的特殊案例研究/系列文章，以及强调来自联盟和会议的发现和挑战的评论。有关癌症发病机制、遗传学、分子诊断、药理学、干细胞、分子靶向、细胞和免疫疗法以及移植的临床研究以及基础和转化研究报告是令人感兴趣的。关注支持性护理、后期影响以及这些领域相关伦理、法律、心理、社会、文化或历史方面的论文也受到赞赏。欢迎对该领域的重要发展进行评论。来自国际儿科血液学和肿瘤学界的科学家和临床医生的文章将被考虑发表。本刊不依赖或与任何组织或社会有联系。所有投稿在发表前都经过严格的同行评审。我们的编委包括儿科血液学和肿瘤学专家，他们代表着广泛的学术和地域多样性。

Pediatric Hematology And Oncology创刊于1986年，由TAYLOR & FRANCIS INC出版商出版，收稿方向涵盖医学 - 小儿科全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度较慢,6-12周，影响因子指数1.232，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。